Inovio Pharmaceuticals
INO • NASDAQ
Inovio Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jacqueline E. Shea, with a market cap of $85.7M.
Market Cap$85.7M
Employees122.0
CEOJacqueline E. Shea
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 12, 2026 · in a monthQ1 2026
Financials
Inovio Pharmaceuticals FAQ
Common questions about Inovio Pharmaceuticals
Inovio Pharmaceuticals is scheduled to report earnings for Q1 2026 on May 12, 2026. Analysts estimate revenue of $250.0K.
Inovio Pharmaceuticals has approximately 122 employees.